Nucleic Acid-Based Therapy Approaches for Huntington's Disease

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) stems from a dominant mutation causing CAG repeat expansion in the huntingtin gene.
• This mutation leads to a toxic gain of function in huntingtin protein, resulting in significant neurodegeneration, primarily in the striatum.
• The complex cellular effects and precise disease mechanisms of HD require further elucidation.

Purpose of the Study:

• To review and outline nucleic acid-based therapeutic strategies for Huntington's disease.
• To summarize the various gene therapy approaches investigated for HD to date.

Main Methods:

• Review of existing literature on gene therapy for Huntington's disease.
• Analysis of strategies targeting different aspects of the disease, including gene expression, protein levels, and cellular metabolism.

Main Results:

• Gene therapy approaches for HD aim to modulate huntingtin gene expression and protein function.
• Interventions include strategies to increase growth factors, decrease mutant huntingtin levels, and restore cellular balance.
• Nucleic acid-based therapies represent a promising avenue for HD treatment.

Conclusions:

• Nucleic acid-based therapies offer diverse strategies to combat Huntington's disease.
• Targeting the genetic and molecular underpinnings of HD is crucial for developing effective treatments.
• Further research into these therapeutic strategies is essential for clinical application.